2024 annual financial data
Travere Therapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -101.84%.
Operating income was -323,827,000 USD and net income was -321,545,000 USD.
Operating cash flow was -237,475,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 233,175,000 USD
- Operating income
- -323,827,000 USD
- Net income
- -321,545,000 USD
- Operating cash flow
- -237,475,000 USD